GLIOMAS
Clinical trials for GLIOMAS explained in plain language.
Never miss a new study
Get alerted when new GLIOMAS trials appear
Sign up with your email to follow new studies for GLIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI reads brain scans to spot tumors without needles
Diagnosis Recruiting nowThis study is building a large database of MRI scans from 3000 adults with brain tumors (glioma, metastases, lymphoma). Researchers will train an artificial intelligence system to automatically identify and classify these tumors. The goal is to make diagnosis faster and more accu…
Matched conditions: GLIOMAS
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Jun 16, 2026 22:20 UTC
-
SmartMatch: could a lab test find the right drug for your brain tumor?
Knowledge-focused Recruiting nowThis study is testing a new technology called SmartMatch that analyzes tumor tissue from people with recurrent brain or spinal cord tumors. The goal is to see if SmartMatch can quickly identify which drugs might work best for each person's specific tumor. About 80 participants ag…
Matched conditions: GLIOMAS
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC
-
Can this drug cross the Brain's barrier to fight tumors?
Knowledge-focused Recruiting nowThis early-stage trial is testing whether the drug ulixertinib can cross the blood-brain barrier in people with recurrent brain tumors called gliomas. About 40 adults will take the drug before surgery to see how much reaches the tumor and how safe it is. The goal is to learn if t…
Matched conditions: GLIOMAS
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC
-
AI reads MRI scans to predict brain tumor type before surgery
Knowledge-focused Recruiting nowThis study is testing whether an artificial intelligence (AI) model can accurately predict the molecular subtype of midline gliomas (a type of brain tumor) using MRI scans taken before surgery. Researchers will compare the AI's predictions with standard lab tests after surgery to…
Matched conditions: GLIOMAS
Sponsor: Xiangya Hospital of Central South University • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:27 UTC